| James Leonard Hubbard, DO | |
|
360 S Herlong Ave, Rock Hill, SC 29732-1160 | |
| (803) 366-4171 | |
| (803) 366-6890 |
| Full Name | James Leonard Hubbard |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 30 Years |
| Location | 360 S Herlong Ave, Rock Hill, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457355497 | NPI | - | NPPES |
| T00530 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 0541 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Piedmont Medical Center | Rock hill, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Piedmont Physician Network Llc | 7911287552 | 96 |
News Archive
At the 2009 Congress of Neurological Surgeons (CNS) Annual Meeting, October 24-28 in New Orleans, Louisiana, Elekta will demonstrate how its line of stereotactic solutions expand treatment capabilities and bring new hope for patients presenting serious conditions.
White House Chief of Staff William Daley told CBS this weekend that President Obama is open to tweaking the health care law - but that he would not "refight the entire fight" over reform. "The president has said he's open to changes to this," Daley told CBS' "Face the Nation," in his first television interview since joining the Obama administration.
Durata Therapeutics today announced the Company has attained worldwide rights for the development and commercialization of Durata's lead product, dalbavancin, a long-acting, intravenous (IV) lipoglycopeptide for the treatment of acute bacterial skin and skin structure infections (abSSSI). In December 2010, Durata acquired from RaQualia Pharma commercialization rights for dalbavancin in Japan.
Medicine-related hospital admissions could be reduced by a simple initiative designed and implemented by researchers at the University of Sydney's Faculty of Pharmacy.
Weightlifting may play a key role in the prevention of the painful limb-swelling condition lymphedema following breast cancer treatment, according to new research from the University of Pennsylvania School of Medicine. Combined with the team's previous findings that the exercise limits a worsening of symptoms among women who already have lymphedema, the new data cements the reversal of long-running advice that breast cancer survivors should avoid lifting anything heavier than five pounds after they finish treatment.
› Verified 4 days ago
| Entity Name | Piedmont Physician Network Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194277186 PECOS PAC ID: 7911287552 Enrollment ID: O20161216001613 |
News Archive
At the 2009 Congress of Neurological Surgeons (CNS) Annual Meeting, October 24-28 in New Orleans, Louisiana, Elekta will demonstrate how its line of stereotactic solutions expand treatment capabilities and bring new hope for patients presenting serious conditions.
White House Chief of Staff William Daley told CBS this weekend that President Obama is open to tweaking the health care law - but that he would not "refight the entire fight" over reform. "The president has said he's open to changes to this," Daley told CBS' "Face the Nation," in his first television interview since joining the Obama administration.
Durata Therapeutics today announced the Company has attained worldwide rights for the development and commercialization of Durata's lead product, dalbavancin, a long-acting, intravenous (IV) lipoglycopeptide for the treatment of acute bacterial skin and skin structure infections (abSSSI). In December 2010, Durata acquired from RaQualia Pharma commercialization rights for dalbavancin in Japan.
Medicine-related hospital admissions could be reduced by a simple initiative designed and implemented by researchers at the University of Sydney's Faculty of Pharmacy.
Weightlifting may play a key role in the prevention of the painful limb-swelling condition lymphedema following breast cancer treatment, according to new research from the University of Pennsylvania School of Medicine. Combined with the team's previous findings that the exercise limits a worsening of symptoms among women who already have lymphedema, the new data cements the reversal of long-running advice that breast cancer survivors should avoid lifting anything heavier than five pounds after they finish treatment.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James Leonard Hubbard, DO 360 S Herlong Ave, Rock Hill, SC 29732-1160 Ph: (803) 366-4171 | James Leonard Hubbard, DO 360 S Herlong Ave, Rock Hill, SC 29732-1160 Ph: (803) 366-4171 |
News Archive
At the 2009 Congress of Neurological Surgeons (CNS) Annual Meeting, October 24-28 in New Orleans, Louisiana, Elekta will demonstrate how its line of stereotactic solutions expand treatment capabilities and bring new hope for patients presenting serious conditions.
White House Chief of Staff William Daley told CBS this weekend that President Obama is open to tweaking the health care law - but that he would not "refight the entire fight" over reform. "The president has said he's open to changes to this," Daley told CBS' "Face the Nation," in his first television interview since joining the Obama administration.
Durata Therapeutics today announced the Company has attained worldwide rights for the development and commercialization of Durata's lead product, dalbavancin, a long-acting, intravenous (IV) lipoglycopeptide for the treatment of acute bacterial skin and skin structure infections (abSSSI). In December 2010, Durata acquired from RaQualia Pharma commercialization rights for dalbavancin in Japan.
Medicine-related hospital admissions could be reduced by a simple initiative designed and implemented by researchers at the University of Sydney's Faculty of Pharmacy.
Weightlifting may play a key role in the prevention of the painful limb-swelling condition lymphedema following breast cancer treatment, according to new research from the University of Pennsylvania School of Medicine. Combined with the team's previous findings that the exercise limits a worsening of symptoms among women who already have lymphedema, the new data cements the reversal of long-running advice that breast cancer survivors should avoid lifting anything heavier than five pounds after they finish treatment.
› Verified 4 days ago
Zachary Alan Shanitkvich, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1721 Ebenezer Rd Ste 145, Rock Hill, SC 29732 Phone: 803-328-2401 | |
Susan Mcbrayer Demchak, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1656 Riverchase Blvd, Ste 3600, Rock Hill, SC 29732 Phone: 803-324-7606 | |
William Samuel Revell, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1656 Riverchase Blvd, Ste 3600, Rock Hill, SC 29732 Phone: 803-324-7606 | |
Frances Poe Bailey, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1721 Ebenezer Rd Ste 145, Rock Hill, SC 29732 Phone: 803-328-2401 Fax: 803-328-1030 | |
Kathryn E. Webb, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1721 Ebenezer Rd Ste 145, Rock Hill, SC 29732 Phone: 803-328-2401 Fax: 803-328-1030 | |
Dr. Roy Norman Taylor, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1721 Ebenezer Rd, Suite 145, Rock Hill, SC 29732 Phone: 803-328-2401 Fax: 803-328-1030 | |
Dr. Barbara L Rowland, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1721 Ebenezer Rd, Suite 145, Rock Hill, SC 29732 Phone: 803-328-2401 Fax: 803-328-1030 |